Soluble micro-needle containing slightly-soluble contraceptives and preparation method of soluble micro-needle

A contraceptive drug and insoluble technology, which is applied in the direction of medical preparations containing active ingredients, medical preparations with non-active ingredients, microneedles, etc., can solve the problems of slow drug transdermal rate and achieve improved transdermal penetration efficiency, Avoid stimulant effects

Inactive Publication Date: 2017-10-10
广州新济薇娜生物科技有限公司
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the currently marketed transdermal preparations are mainly patches. Due to the slow drug transdermal rate of patches, it is difficult to deliver a large

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Soluble micro-needle containing slightly-soluble contraceptives and preparation method of soluble micro-needle
  • Soluble micro-needle containing slightly-soluble contraceptives and preparation method of soluble micro-needle
  • Soluble micro-needle containing slightly-soluble contraceptives and preparation method of soluble micro-needle

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] This embodiment provides a soluble microneedle containing a poorly soluble contraceptive drug and a preparation method thereof, the preparation method comprising the following steps:

[0045] 1) Preparation of base solution

[0046] Weigh 1 g of dextran 40 and dissolve it in 2 mL of deionized water, and swell overnight to obtain a base solution.

[0047] 2) Preparation of levonorgestrel cyclodextrin inclusion compound

[0048] Weigh 2g hydroxypropyl-β-cyclodextrin (1.3×10^ -3 mol) was dissolved in 2mL deionized water, and after stirring until completely dissolved, 0.03g levonorgestrel (9.6×10^ -5 mol), the mol ratio of levonorgestrel to hydroxypropyl-β-cyclodextrin is 1:13, and the magnetic stirring reaction is 2h, and then the solution is freeze-dried for 48h to obtain the levonorgestrel-cyclodextrin package compound.

[0049] 3) Preparation of needle tip solution

[0050] Weigh 1 g of dextran 40, dissolve it in 2 mL of deionized water, and swell overnight to obta...

Embodiment 2

[0054] This embodiment provides a soluble microneedle containing a poorly soluble contraceptive drug and a preparation method thereof, the preparation method comprising the following steps:

[0055] 1) Preparation of base solution

[0056] With embodiment 1.

[0057] 2) Preparation of levonorgestrel cyclodextrin inclusion compound

[0058] Weigh 6g hydroxypropyl-β-cyclodextrin (3.9×10^ -3 mol) was dissolved in 6mL deionized water, and after stirring until completely dissolved, 0.03g levonorgestrel (9.6×10^ -5 mol), the mol ratio of levonorgestrel to hydroxypropyl-β-cyclodextrin is 1:40, magnetic stirring reaction 2h, then this solution is freeze-dried 48h, obtains levonorgestrel cyclodextrin package compound.

[0059] 3) Preparation of needle tip solution

[0060] With embodiment 1.

[0061] 4) Preparation of soluble microneedles loaded with levonorgestrel

[0062] With embodiment 1.

Embodiment 3

[0064] This embodiment provides a soluble microneedle containing a poorly soluble contraceptive drug and a preparation method thereof, the preparation method comprising the following steps:

[0065] 1) Preparation of base solution

[0066] With embodiment 1.

[0067] 2) Preparation of levonorgestrel cyclodextrin inclusion compound

[0068] With embodiment 1.

[0069] 3) Preparation of needle tip solution

[0070] Weigh 1 g of dextran 40, dissolve it in 2 mL of deionized water, and swell overnight to obtain a dextran solution; weigh 1 g of levonorgestrel cyclodextrin inclusion compound and dissolve it in 1 mL of deionized water to obtain a drug-containing solution. Mix the dextran solution and the drug-containing solution at a ratio of 1:2 (v / v) to obtain the needle tip solution.

[0071] 4) Preparation of soluble microneedles loaded with levonorgestrel

[0072] With embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a soluble micro-needle containing slightly-soluble contraceptives and a preparation method of the soluble micro-needle. The soluble micro-needle comprises a base and a needle tip, wherein the needle tip is prepared by a cyclodextrin inclusion compound, a micro-needle framework material and a solvent, the cyclodextrin inclusion compound is prepared by the slightly-soluble contraceptives, beta-cyclodextrin and a solvent, and the mole ratio of the slightly-soluble contraceptives to the beta-cyclodextrin is 1:(1-40); the micro-needle framework material is selected from at least one of dextran, hyaluronic acid and chitosan; the mass ratio of the micro-needle framework material to the cyclodextrin inclusion compound is 1:(0.2-5). The soluble micro-needle has the advantages that the soluble micro-needle is good in mechanical performance and good in percutaneous absorption effect; compared with a traditional transdermal patch, the soluble micro-needle greatly increases the percutaneous penetration efficiency of drugs, has similar effects as oral-taking preparations and avoids drug irritation to gastrointestinal tracts.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a soluble microneedle containing a poorly soluble contraceptive drug and a preparation method thereof. Background technique [0002] Contraceptives, especially emergency contraceptives, are one of the commonly used contraceptive methods at present. The dosage forms of this type of drugs are mainly single drugs or compound preparations. Common dosage forms include tablets, drop pills and implants. Among them, the application of tablets most. However, during the use of the tablet, the gastrointestinal tract will be irritated and cause vomiting, which requires repeated administration, resulting in low compliance. Researchers at home and abroad have been committed to improving the shortcomings of traditional dosage forms to meet the contraceptive needs of different groups of people. [0003] Among many dosage forms, transdermal drug delivery has broad applicatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/00A61K47/69A61K45/00A61K47/26A61K47/36A61P15/18A61K31/567
CPCA61K45/00A61K47/26A61K47/36A61K9/0021A61K31/567A61M2037/0046A61M2037/0053
Inventor 陈航平李革姚港涛任春艳
Owner 广州新济薇娜生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap